AzTrials
AzTrials

Dentine HypersensitivityNCT07056855

Three Different Topically Applied Materials as Non-invasive Treatment of Sensitivity in Permanent Teeth With Molar Incisor Hypomineralization

A study testing nano hydroxy apatite varnish Intervention (1), Potassium Nitrate Gel and Varnishes, Fluorid in people with Dentine Hypersensitivity, run by Cairo University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This clinical study main goal is to investigate the effectiveness of nano hydroxy apatite crystal varnish and potassium nitrate gel as a non invasive approach in managing Dentin Hypersensitivity in MIH-affected teeth. Read more about this study

Who is it for?
Ages 6 to 10 yearsHealthy volunteers can take part
Conditions the study is for
Dentine Hypersensitivity
What is being tested?
nano hydroxy apatite varnish Intervention (1), Potassium Nitrate Gel and Varnishes, Fluorid
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
No sites listed yet
Study dates
10 Jul 2025to 20 Jul 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

None listed.

Who cannot join

  • Participants related criteria:
  • Children with severe behavioral or emotional disabilities.
  • Children who received analgesics within the last 24 hours before the procedure.
  • Patients who are using chlorhexidine-based gels or mouthwashes.
  • Tooth related criteria:
  • A tooth with signs and symptoms of irreversible pulpitis.
Show all 10Show fewer
  • A tooth with signs and symptoms of necrotic pulp.
  • Sealing therapy or application of desensitizing agent on the MIH teeth within one month before participation in the study.
  • Presence of dental caries on the MIH-affected permanent tooth.
  • Presence of restoration(s) on MIH-affected permanent tooth.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Mennat Allah A. A. Abd Elsabour, PhD student contact

+201026022605

mennatallah.ashraf@dentistry.cu.edu.eg

About this study

Official title: Comparative Evaluation of Nano Hydroxy Apatite Varnish and Potassium Nitrate Gel Versus Fluoride Varnish as Non-invasive Treatment of Dentin Hypersensitivity in Permanent Teeth With Molar Incisor Hypo-mineralization: Randomized Clinical Trial

This clinical study main goal is to investigate the effectiveness of nano hydroxy apatite crystal varnish and potassium nitrate gel as a non invasive approach in managing Dentin Hypersensitivity in MIH-affected teeth.

Read the detailed description

This randomized clinical trial study aims to investigate the effectiveness of nano-hydroxy apatite crystal varnish, and potassium nitrate gel compared to fluoride varnish, in reducing dentin hypersensitivity, improving a child's oral hygiene.

Being tested
nano hydroxy apatite varnish Intervention (1), Potassium Nitrate Gel, Varnishes, Fluorid
Medical subject headings
Dentin Sensitivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • nano hydroxy apatite varnish Intervention (1)Drug

    Fygg's professional strength, Fygg, USA

  • Potassium Nitrate GelDrug

    Ultradent UltraEZ Desensitizing Gel, Ultradent Inc., USA

  • Varnishes, FluoridDrug

    DentKist Charm Varnish 5% Sodium Fluoride Varnish

Study groups in NCT07056855
Study groupRoleWhat they receive
8.6% nano-hydroxy apatite crystals varnish (Fygg's professional strength, Fygg, USA).ExperimentalIntervention group (1)
Receives: Drug: nano hydroxy apatite varnish Intervention (1)
Potassium Nitrate (Ultradent UltraEZ Desensitizing Gel, Ultradent Inc., USA).ExperimentalIntervention group (2)
Receives: Drug: Potassium Nitrate Gel
5% fluoride varnish Control groupActive comparatorNot described
Receives: Drug: Varnishes, Fluorid

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dentin Hypersensitivity

    Face scale: scores from 0-4. the higher the score the worse the sensitivity

    Measured: Baseline, 15 miutes pot-op, 2 weeks post-op, and 4 weeks post op

  2. Dentin Hypersensitivity

    chiff Cold Air Blasting Sensitivity Scale: scores from 0-3. The higher the score the worse the sensitivity.

    Measured: Baseline, 15 miutes pot-op, 2 weeks post-op, and 4 weeks post op

Secondary outcomes (1)
  1. Oral hygiene

    Measured by Plaque Control Record: Percentage.

    Measured: baseline, 2-, and 4- week post-op

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2025
  2. Study start10 Jul 2025 (estimated)
  3. Primary completion20 Jul 2025 (estimated)
  4. Study completion20 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07056855
Sponsor's protocol ID
1444
Status last verified
Mar 2025
First submitted
29 Jun 2025
Last updated
9 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing nano hydroxy apatite varnish Intervention (1), Potassium Nitrate Gel and Varnishes, Fluorid in people with Dentine Hypersensitivity, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mennat Allah A. A. Abd Elsabour, PhD student (+201026022605, mennatallah.ashraf@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dentin Hypersensitivity (time frame: Baseline, 15 miutes pot-op, 2 weeks post-op, and 4 weeks post op). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in